Acadia Pharmaceuticals

495 articles with Acadia Pharmaceuticals

• ACADIA Pharmaceuticals, Inc. Announces Positive Results From Phase II Trial Of ACP-103 For Treatment-Induced Psychosis In Patients With Parkinson's Disease

  3/24/2006

• ACADIA Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences

  3/2/2006

• ACADIA Pharmaceuticals, Inc. Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2005

  3/2/2006

• ACADIA Pharmaceuticals, Inc. To Announce Fourth Quarter And Full Year 2005 Results On March 1, 2006

  2/22/2006

• ACADIA Pharmaceuticals, Inc. Announces Advancements In Two Preclinical Programs

  2/21/2006

• ACADIA Pharmaceuticals, Inc. To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference 2006 On February 14, 2006

  2/7/2006

• Sepracor, Inc. Buys ACADIA Pharmaceuticals, Inc. Shares In Partnership

  1/17/2006

• ACADIA Pharmaceuticals, Inc. Announces Appointment Of David C. Furlano, Ph.D., As Vice President, Regulatory Affairs

  1/9/2006

• ACADIA Pharmaceuticals, Inc. Discovers Novel Isoform-Selective Retinoic Acid Receptor Agonists

  12/15/2005

• ACADIA Pharmaceuticals, Inc. Reports Results From Phase II Study Of ACP-103; Trial Misses Primary Target

  12/1/2005

• ACADIA Pharmaceuticals, Inc. Reports Third Quarter 2005 Financial Results

  11/11/2005

• ACADIA Pharmaceuticals, Inc. Announces Initial Results From Ongoing Single-Dose Clinical Trial Of ACP-104 In Schizophrenia Patients

  11/11/2005

• ACADIA Pharmaceuticals, Inc. To Announce Third Quarter 2005 Financial Results On November 10, 2005

  11/3/2005

• ACADIA Pharmaceuticals, Inc. To Present At The Rodman & Renshaw Techvest 7th Annual Healthcare Conference On November 8, 2005

  11/1/2005

• The Day In Review: Biotech Slumps Again

  6/22/2005